about
Association of human herpesvirus-6B with mesial temporal lobe epilepsyMechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factorNeurological surgery at the National Institutes of Health.New developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in gliomaCollaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 diseaseDetection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resectionsPathogenesis and Cerebrospinal Fluid Hydrodynamics of the Chiari I MalformationPathophysiology of primary spinal syringomyeliaTemporal lobectomy: resection volume, neuropsychological effects, and seizure outcome.The post-syrinx syndrome: stable central myelopathy and collapsed or absent syrinx.High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances.Image-guided convection-enhanced delivery of muscimol to the primate brainVon hippel-lindau disease associated pulmonary carcinoid with cranial metastasisCholesterol homeostatic responses provide biomarkers for monitoring treatment for the neurodegenerative disease Niemann-Pick C1 (NPC1)Magnetic resonance imaging properties of convective delivery in diffuse intrinsic pontine gliomas."Hidden" bone metastasis from thyroid carcinoma: a clinical note.Technique for enhanced accuracy and reliability in non-human primate stereotaxy.Surgical management of melanoma brain metastases in patients treated with immunotherapy.Intraoperative infrared imaging of brain tumorsClinical and neuroimaging features of "idiopathic" syringomyelia.Effect of craniovertebral decompression on CSF dynamics in Chiari malformation type I studied with computational fluid dynamics: Laboratory investigationInsertion of mutant proteolipid protein results in missorting of myelin proteins.Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapyProtein Phosphatase 2A Inhibition with LB100 Enhances Radiation-Induced Mitotic Catastrophe and Tumor Growth Delay in Glioblastoma.Rapidly progressing monoparesis caused by Chiari malformation type I without syringomyelia.PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells.Hypotaurine evokes a malignant phenotype in glioma through aberrant hypoxic signaling.Convection-enhanced delivery of M13 bacteriophage to the brainCortical mapping and frameless stereotactic navigation in the high-field intraoperative magnetic resonance imaging suitePET of serotonin 1A receptors and cerebral glucose metabolism for temporal lobectomy.Accuracy of direct magnetic resonance imaging-guided placement of drug infusion cannulae.Characterization of the blood brain barrier in pediatric central nervous system neoplasms.Diagnosis of a growing radiation-induced skull lesion in a patient: an unusual scar.ZEB1 expression is increased in IDH1-mutant lower-grade gliomas.Tumors displaying hybrid schwannoma and neurofibroma features in patients with neurofibromatosis type 2.Brief report: relief of spinal cord compression from vertebral hemangioma by intralesional injection of absolute ethanol.Real-time detection of vascular occlusion and reperfusion of the brain during surgery by using infrared imaging.Diskogenic diseases of the spine: clinical aspects.Brain metastasis after immunotherapy in patients with metastatic melanoma or renal cell cancer: is craniotomy indicated?MB-12INDUCED CISPLATIN RESISTANCE IN MEDULLOBLASTOMAS.
P50
Q21144668-FB86FCDE-2393-4890-B8E6-D7E7E36D1498Q24561970-8E05C429-3AAD-4D66-BD58-F8DEB63FE17EQ24633733-D9879F95-162A-4967-B647-DB8224D8967CQ26863394-A26655AD-9035-471F-8F06-BA1C5724582EQ27006029-12AEC7C0-60AC-41EA-A492-82F129A0F610Q28187478-0DD60EBD-0B21-44D9-A96C-FF98684EED6FQ30278623-CB4C720F-5F56-4DB6-9B2F-801269171023Q30416967-1355DF81-DCE8-428E-AA83-49C1740B975AQ30479302-F7749043-D08E-466B-B0E4-788CCE81B4B5Q31033363-F4242B06-81D7-4BFF-AF39-1DDA61507A23Q33259264-D6662782-408A-4C41-A7EF-DFBD552BFF5DQ33785767-4BAC5EA8-1FF2-453A-B215-143E56E49E69Q33998954-CED07014-8931-411C-83A0-14D769FBFAB8Q34379062-48031E50-698D-4F6F-A93F-B0BD7C4F63FEQ34954842-855BEB36-0CAE-4662-8C72-23FF20C14BE0Q34954898-5A21D8AB-19D9-413A-B0B1-A9388FAD5543Q34954972-EE5C4427-DA6C-472D-BFBD-6A9B1F8BA9C9Q34954990-3683BE82-0E15-4367-98D4-A32BC2382944Q34955005-C465616C-B9E4-4A86-8CB7-92AA2782EACCQ34955371-455A7684-D2F7-4556-B9E3-2467D2BE412FQ34955927-944A96BB-3E6F-4647-B75B-FD75709B3951Q34955982-FD8EDE45-06F5-464E-AAB1-841BC92DC776Q35828461-99830B24-C9BE-480D-AB1D-71A8DAE34A6CQ35836388-8EE70A08-CF28-4468-AD1F-30E59D33A85CQ36999684-4B1228AF-4E88-477F-9B1F-CFC7CA198ADDQ37022200-1F16D790-DB1D-4C2F-BC8A-4E07272BB550Q37046847-8FACB763-EBB2-4E32-8A26-119639DD8BF0Q37205691-B77A1D7F-07FE-45C2-A8ED-D982E4098D8DQ37238084-CF55866D-F5DD-4837-AB93-6008734D2002Q37376729-083E06EE-2733-41A1-94E0-6D98A408C917Q37436122-373BF775-3082-4E21-A19F-9D9774704ED0Q37462324-74428E56-4A73-4675-98D4-4780F1128408Q37486116-8F1510F0-A939-4F45-A9EA-37FD748B7FB7Q38438838-88BE19E4-A8DD-457A-8C9B-E466A76F4409Q38681082-1C9C0BF2-5A69-464B-9A04-6E9C1CA2BE2CQ39482275-D73EED49-C334-440E-A74E-ED643FD958E7Q39602345-132ACE62-BD21-4329-96F9-CFA476A512C2Q39641071-745A566E-3158-4243-9EA9-BAA32384872AQ45077693-FFE68BBC-619D-43D7-8414-08E5E2EBA99BQ45956041-F33D66A1-F09E-498B-9456-B828D7CB2F54
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John Heiss
@ast
John Heiss
@en
John Heiss
@es
John Heiss
@nl
John Heiss
@sl
type
label
John Heiss
@ast
John Heiss
@en
John Heiss
@es
John Heiss
@nl
John Heiss
@sl
prefLabel
John Heiss
@ast
John Heiss
@en
John Heiss
@es
John Heiss
@nl
John Heiss
@sl
P106
P31
P496
0000-0002-3890-0165